서울시 서초구 반포대로 222 가톨릭대학교 성의교정 / TEL : 02-2258-7114 / FAX : 02-532-6537

222 Banpo-daero Seocho-gu, Seoul, (06591) Republic of korea / TEL : +82-2-2258-7114 / FAX : +82-2-532-6537

​Publication

​Publication

International journal publications (SCI)

2019

HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.

Yang HD, Kim HS, Kim SY, Na MJ, Yang G, Eun JW, Wang HJ, Cheong JY, Park WS, Nam SW.

Hepatology. 2019 Apr 16. doi: 10.1002/hep.30657. [Epub ahead of print]

 

NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production.

Yoon JH, Lee YS, Kim O, Ashktorab H, Smoot DT, Nam SW, Park WS.

World J Gastroenterol. 2019 Jan 21;25(3):330-345. doi: 10.3748/wjg.v25.i3.330.

2018

Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.

Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.

Int J Oncol. 2018 Jul;53(1):395-403. doi: 10.3892/ijo.2018.4392. Epub 2018 May 2.

 

Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.

Shen Q*, Eun JW*, Lee K*, Kim HS, Yang HD, Kim SY, Lee EK, Kim T, Kang K, Kim S, Min DH, Oh SN, Lee YJ, Moon H, Ro SW, Park WS, Lee JY, Nam SW.

Hepatology. 2018 Apr;67(4):1360-1377. doi: 10.1002/hep.29606.Epub 2018 Feb 20.

Gastrokine 1 protein is a potential theragnostic target for gastric cancer.

Yoon JH, Ham IH, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Hur H, Park WS.

Gastric Cancer. 2018 Apr 27. doi: 10.1007/s10120-018-0828-8. [Epub ahead of print]

SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.

Shen Q, Nam SW.

BMB Rep. 2018 Feb;51(2):57-58.

T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.

Yang HD, Eun JW, Lee KB, Shen Q, Kim HS, Kim SY, Seo DW, Park WS, Lee JY, Nam SW.

Exp Mol Med. 2018 Jan 5;50(1):e420. doi: 10.1038/emm.2017.166.

MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.

Eun JW, Kim HS, Shen Q, Yang HD, Kim SY, Yoon JH, Park WS, Lee JY, Nam SW.

J Pathol. 2018 Jan;244(1):107-119. doi: 10.1002/path.4994. Epub 2017 Nov 27.

Deciphering cellular and molecular causes of the tumor functional heterogeneity of liver cancer.

Nam SW.

Exp Mol Med. 2018 Jan 5;50(1):e415. doi: 10.1038/emm.2017.188. No abstract available.

2017

Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.

Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW, Han KH, Calvisi DF, Ro SW.

Gastroenterology. 2017 Nov;153(5):1378-1391.e6. doi: 10.1053/j.gastro.2017.07.014. Epub 2017 Jul 20.

Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29.

Choi SK, Pandiyan K, Eun JW, Yang X, Hong SH, Nam SW, Jones PA, Liang G, You JS.

Oncotarget. 2017 Oct 9;8(58):98322-98335. doi: 10.18632/oncotarget.21681. eCollection 2017 Nov 17.

NKX6.3 Regulates Reactive Oxygen Species Production by Suppressing NF-kB and DNMT1 Activities in Gastric Epithelial Cells.

Yoon JH, Kim O, Nam SW, Lee JY, Park WS.

Sci Rep. 2017 Jun 5;7(1):2807. doi: 10.1038/s41598-017-02901-y.

Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2017 Sep;20(5):772-783. doi: 10.1007/s10120-017-0692-y. Epub 2017 Feb 1.

 

Identification of novel biomarkers for prediction of neurological prognosis following cardiac arrest.

Eun JW, Yang HD, Kim SH, Hong S, Park KN, Nam SW, Jeong S.

Oncotarget. 2017 Jan 28. doi: 10.18632/oncotarget.14877.

 

2016

T-cell-restricted intracellular antigen 1 facilitates mitochondrial fragmentation by enhancing the expression of mitochondrial fission factor.

Tak H, Eun JW, Kim J, Park SJ, Kim C, Ji E, Lee H, Kang H, Cho DH, Lee K, Kim W, Nam SW, Lee EK.

Cell Death Differ. 2017 Jan;24(1):49-58. doi: 10.1038/cdd.2016.90.

 

NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression.

Yoon JH, Eun JW, Choi WS, Kim O, Nam SW, Lee JY, Park WS.

EBioMedicine. 2016 Jul;9:97-109. doi: 10.1016/j.ebiom.2016.05.027. Epub 2016 May 25.

 

Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.

Yoon JH, Choi WS, Kim O, Choi BJ, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2016 Jun 1. [Epub ahead of prin

 

Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.

Hong SH, Eun JW, Choi SK, Shen Q, Choi WS, Han JW, Nam SW, You JS.

Oncotarget. 2016 Apr 12. doi: 10.18632/oncotarget.8701. [Epub ahead of print]

 

Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.

Yang HD, Kim PJ, Eun JW, Shen Q, Kim HS, Shin WC, Ahn YM, Park WS, Lee JY, Nam SW.

Oncotarget. 2016 Mar 8;7(10):11412-23. doi: 10.18632/oncotarget.7194.

 

Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.

Yoon JH, Choi SS, Kim O, Choi WS, Park YK, Nam SW, Lee JY, Park WS.

Mod Pathol. 2016 Feb;29(2):194-208. doi: 10.1038/modpathol.2015.150. Epub 2016 Jan 8.

 

JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms.

Choi SK, Hong SH, Kim HS, Shin CY, Nam SW, Choi WS, Han JW, You JS.

Oncol Rep. 2016 Feb;35(2):1186-94. doi: 10.3892/or.2015.4410. Epub 2015 Nov 11.

 

Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.

Park EK, Lee JC, Park JW, Bang SY, Yi SA, Kim BK, Park JH, Kwon SH, You JS, Nam SW, Cho EJ, Han JW.

Cell Death Dis. 2015 Nov 5;6:e1964. doi: 10.1038/cddis.2015.313.

 

Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model.

Chung SI, Moon H, Ju HL, Cho KJ, Kim do Y, Han KH, Eun JW, Nam SW, Ribback S, Dombrowski F, Calvisi DF, Ro SW.

J Hepatol. 2016 Mar;64(3):618-27. doi: 10.1016/j.jhep.2015.10.007. Epub 2015 Oct 22.

 

Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.

Kang H, Kim C, Lee H, Rho JG, Seo JW, Nam JW, Song WK, Nam SW, Kim W, Lee EK.

Cell Death Differ. 2016 Mar;23(3):484-95. doi: 10.1038/cdd.2015.116. Epub 2015 Sep 4

 

2015

 

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.

Kim HS, Shen Q, Nam SW.

J Korean Med Sci. 2015 Oct;30(10):1375-80. doi: 10.3346/jkms.2015.30.10.1375. Epub 2015 Sep 12. Review

 

NKX6.3 controls gastric differentiation and tumorigenesis.

Yoon JH, Choi WS, Kim O, Choi SS, Lee EK, Nam SW, Lee JY, Park WS.

Oncotarget. 2015 Sep 29;6(29):28425-39. doi: 10.18632/oncotarget.4952.

 

Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.

Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY, Park WS.

World J Gastroenterol. 2015 Aug 21;21(31):9328-36. doi: 10.3748/wjg.v21.i31.9328.

 

Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction.

Park HJ, Noh JH, Eun JW, Koh YS, Seo SM, Park WS, Lee JY, Chang K, Seung KB, Kim PJ, Nam SW.

Oncotarget. 2015 May 30;6(15):12970-83.

 

MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer.

Bae HJ, Jung KH, Eun JW, Shen Q, Kim HS, Park SJ, Shin WC, Yang HD, Park WS, Lee JY, Nam SW.

J Hepatol. 2015 Mar 25. pii: S0168-8278(15)00202-0. doi: 10.1016/j.jhep.2015.03.019. [Epub ahead of print]

 

MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.

Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Yang HD, Park M, Park WS, Kang YK, Nam SW.

Oncotarget. 2015 Apr 10;6(10):8089-102.

 

Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis.

Chung YJ, Kim HJ, Park SH, Yoon JH, Kim MR, Nam SW, MacLaughlin DT, Donahoe PK, Kim JH.

Int J Oncol. 2015 May;46(5):2039-46. doi: 10.3892/ijo.2015.2920. Epub 2015 Mar 6.

 

Gastrokine 1 inhibits gastrin-induced cell proliferation.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2015 Mar 10. [Epub ahead of print]

 

 

2014

 

miR-27 regulates mitochondrial networks by directly targeting the mitochondrial fission factor.

Tak H, Kim J, Jayabalan AK, Lee H, Kang H, Cho DH, Ohn T, Nam SW, Kim W, Lee EK.

Exp Mol Med. 2014 Nov 28;46:e123. doi: 10.1038/emm.2014.73

 

Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer.

Yoon JH, Seo HS, Choi WS, Kim O, Nam SW, Lee JY, Park WS.

Oncotarget. 2014 Nov 30;5(22):11695-708.

 

Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA.

Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Carcinogenesis. 2014 Nov;35(11):2619-29. doi: 10.1093/carcin/bgu199. Epub 2014 Sep 19.

 

Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.

Eun JW, Bae HJ, Shen Q, Park SJ, Kim HS, Shin WC, Yang HD, Jin CY, You JS, Kang HJ, Kim H, Ahn YM, Park WS, Lee JY, Nam SW.

J Appl Toxicol. 2015 Feb;35(2):152-64. doi: 10.1002/jat.3062. Epub 2014 Sep 18.

 

HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer.

Park SJ, Kim JK, Bae HJ, Eun JW, Shen Q, Kim HS, Shin WC, Yang HD, Lee EK, You JS, Park WS, Lee JY, Nam SW.

Cancer Lett. 2014 Nov 1;354(1):97-106. doi: 10.1016/j.canlet.2014.07.041. Epub 2014 Aug 8.

 

The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer.

Shim JH, Yoon JH, Choi SS, Ashktorab H, Smoot DT, Song KY, Nam SW, Lee JY, Park CH, Park WS.

Gene. 2014 Aug 10;546(2):288-96. doi: 10.1016/j.gene.2014.05.064. Epub 2014 May 28.

 

Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.

Lee JY, Kim SY, Mo EY, Kim ES, Han JH, Maeng LS, Lee AH, Eun JW, Nam SW, Moon SD.

Int J Oncol. 2014 Aug;45(2):641-50. doi: 10.3892/ijo.2014.2477. Epub 2014 May 29.

 

A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.

Lee H, Kim C, Ku JL, Kim W, Yoon SK, Kuh HJ, Lee JH, Nam SW, Lee EK.

Mol Cells. 2014 Jul;37(7):540-6. doi: 10.14348/molcells.2014.0151. Epub 2014 Jul 31.

 

GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Physiol. 2014 Jun;229(6):762-71. doi: 10.1002/jcp.24496.

 

Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers.

Choi YJ, Song JH, Yoon JH, Choi WS, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2014 Apr;17(2):247-54. doi: 10.1007/s10120-013-0277-3. Epub 2013 Jun 28.

 

MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer.

Shen Q, Bae HJ, Eun JW, Kim HS, Park SJ, Shin WC, Lee EK, Park S, Park WS, Lee JY, Nam SW.

Cancer Lett. 2014 Mar 28;344(2):204-11. doi: 10.1016/j.canlet.2013.10.030. Epub 2013 Nov 1.

 

MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.

Bae HJ, Noh JH, Kim JK, Eun JW, Jung KH, Kim MG, Chang YG, Shen Q, Kim SJ, Park WS, Lee JY, Nam SW.

Oncogene. 2014 May 15;33(20):2557-67. doi: 10.1038/onc.2013.216. Epub 2013 Jun 3.

 

HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.

Noh JH, Bae HJ, Eun JW, Shen Q, Park SJ, Kim HS, Nam B, Shin WC, Lee EK, Lee K, Jang JJ, Park WS, Lee JY, Nam SW.

Cancer Res. 2014 Mar 15;74(6):1728-38. doi: 10.1158/0008-5472.CAN-13-2109. Epub 2014 Jan 21.

Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness.

Hong SH, Yang SJ, Kim TM, Shim JS, Lee HS, Lee GY, Park BB, Nam SW, Ryoo ZY, Oh IH.

Stem Cells. 2014 May;32(5):1313-22. doi: 10.1002/stem.1631.

 

Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer.

Kim HS, Chang YG, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Lee EK, Park S, Ahn YM, Park WS, Lee JY, Nam SW.

FEBS J. 2014 Feb;281(3):851-61.

 

GKN2 Contributes to the Homeostasis of Gastric Mucosa by Inhibiting GKN1 Activity.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Physiol. 2014 Jun;229(6):762-71. doi: 10.1002/jcp.24496.

 

Association of IL-17A and IL-17F single nucleotide polymorphisms with susceptibility to osteoarthritis in a Korean population.

Han L, Lee HS, Yoon JH, Choi WS, Park YG, Nam SW, Lee JY, Park WS.

Gene. 2014 Jan 1;533(1):119-22. doi: 10.1016/j.gene.2013.09.113. Epub 2013 Oct 3.

 

The single nucleotide polymorphism (SNP) of the estrogen receptor-β gene, rs1256049, is associated with knee osteoarthritis in Korean population.

Lee SW, Song JH, Choi WS, Yoon JH, Kim O, Park YG, Nam SW, Lee JY, Park WS.

Knee. 2014 Jan;21(1):242-6. doi: 10.1016/j.knee.2012.12.011. Epub 2013 Jan 23.

 

 

2010~2013

 

Gastrokine 1 expression in the human gastric mucosa is closely associated with the degree of gastritis and DNA methylation.

Choi WS, Seo HS, Song KY, Yoon JH, Kim O, Nam SW, Lee JY, Park WS.

J Gastric Cancer. 2013 Dec;13(4):232-41. doi: 10.5230/jgc.2013.13.4.232. Epub 2013 Dec 31.

 

Characteristic molecular signatures of early exposure to volatile organic compounds in rat liver.

Kim JK, Eun JW, Bae HJ, Shen Q, Park SJ, Kim HS, Park S, Ahn YM, Park WS, Lee JY, Nam SW.

Biomarkers. 2013 Dec;18(8):706-15. doi: 10.3109/1354750X.2013.847121. Epub 2013 Oct 21.

 

Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1.

Yoon JH, Choi YJ, Choi WS, Nam SW, Lee JY, Park WS.

Biochem Biophys Res Commun. 2013 Oct 5. doi:pii: S0006-291X(13)01628-8. 10.1016/j.bbrc.2013.09.123. [Epub ahead of print]

 

Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model.

Yeon SE, No da Y, Lee SH, Nam SW, Oh IH, Lee J, Kuh HJ.

PLoS One. 2013 Sep 10;8(9):e73345. doi: 10.1371/journal.pone.0073345.

 

GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle.

Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot D, Nam SW, Lee JY, Park WS.

Clin Cancer Res. 2013 Jul 11. [Epub ahead of print]

 

Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers.

Choi YJ, Song JH, Yoon JH, Choi WS, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2013 Jun 28. [Epub ahead of print]

 

Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.

Oh JE, Kim JO, Shin JY, Zhang XH, Won HS, Chun SH, Jung CK, Park WS, Nam SW, Eun JW, Kang JH.

Int J Oncol. 2013 Aug;43(2):383-93. doi: 10.3892/ijo.2013.1953. Epub 2013 May 24.

 

MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.

Noh JH, Chang YG, Kim MG, Jung KH, Kim JK, Bae HJ, Eun JW, Shen Q, Kim SJ, Kwon SH, Park WS, Lee JY, Nam SW.

Cancer Lett. 2013 Mar 14.

 

Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers.

Yoon JH, La Cho M, Choi YJ, Back JY, Park MK, Lee SW, Choi BJ, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Biochem. 2013 Feb 26. 

 

The single nucleotide polymorphism (SNP) of the estrogen receptor-β gene, rs1256049, is associated with knee osteoarthritis in Korean population.

Lee SW, Song JH, Choi WS, Yoon JH, Kim O, Park YG, Nam SW, Lee JY, Park WS.

Knee. 2013 Jan 23.

 

Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.

Kim JK, Noh JH, Eun JW, Jung KH, Bae HJ, Shen Q, Kim MG, Chang YG, Kim SJ, Park WS, Lee JY, Borlak J, Nam SW.

Mol Cancer Res. 2013 Jan;11(1):62-73.

 

Characteristic molecular signature for the early detection and prediction of polycyclic aromatic hydrocarbons in rat liver.

Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Kim SJ, Kwon SH, Park WS, Lee JY, Nam SW.

Toxicol Lett. 2013 Jan 10;216(1):1-8

Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition.

Hwang SH, Lee BH, Kim HJ, Cho HJ, Shin HC, Im KS, Choi SH, Shin TJ, Lee SM, Nam SW, Kim HC, Rhim H, Nah SY.

Int J Oncol. 2013 Jan;42(1):317-26. doi: 10.3892/ijo.2012.1709. Epub 2012 Nov 20.

 

MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.

Hunecke D, Spanel R, Länger F, Nam SW, Borlak J.

J Pathol. 2012 May 31.

 

DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Bae HJ, Chang YG, Noh JH, Kim JK, Eun JW, Jung KH, Kim MG, Shen Q, Ahn YM, Kwon SH, Park WS, Lee JY, Nam SW.

Oncol Lett. 2012 Nov;4(5):873-877. Epub 2012 Aug 23.

 

Characteristic molecular signature for early detection and prediction of persistent organic pollutants in rat liver.

Jung KH, Kim JK, Kim MG, Noh JH, Eun JW, Bae HJ, Chang YG, Shen Q, Park WS, Lee JY, Nam SW.

Environ Sci Technol. 2012 Dec 4;46(23):12882-9

 

Characteristic molecular signature for the early detection and prediction of polycyclic aromatic hydrocarbons in rat liver.

Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Kim SJ, Kwon SH, Park WS, Lee JY, Nam SW.

Toxicol Lett. 2013 Jan 10;216(1):1-8

 

TNF-α and TNF-β Polymorphisms are Associated with Susceptibility to Osteoarthritis in a Korean Population.

Han L, Song JH, Yoon JH, Park YG, Lee SW, Choi YJ, Nam SW, Lee JY, Park WS.

Korean J Pathol. 2012 Feb;46(1):30-7. doi: 10.4132/KoreanJPathol.2012.46.1.30. Epub 2012 Feb 23

 

Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.

Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS, Lee JY, Borlak J, Nam SW.

Hepatology. 2013 Mar;57(3):1055-67.

 

Association of SOD1 and SOD2 single nucleotide polymorphisms with susceptibility to gastric cancer in a Korean population.

Han L, Lee SW, Yoon JH, Park YG, Choi YJ, Nam SW, Lee JY, Wang YP, Park WS.

APMIS. 2013 Mar;121(3):246-56. 

 

HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer.

Xie HJ, Noh JH, Kim JK, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Lee JY, Park H, Nam SW.

PLoS One. 2012;7(4):e34265. Epub 2012 Apr 4.

 

HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.

Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Xie HJ, Chang YG, Kim MG, Park H, Lee JY, Nam SW.

J Cell Biochem. 2012 Jun;113(6):2167-77. doi: 10.1002/jcb.24090.

 

Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.

Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Chang YG, Kim MG, Park WS, Lee JY, Lee SY, Chu IS, Nam SW.

Hepatology. 2012 Aug;56(2):644-57. doi: 10.1002/hep.25699. Epub 2012 Jun 11.

 

PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. 

Cao Z, Yoon JH, Nam SW, Lee JY, Park WS.

J Cancer Res Clin Oncol. 2012 Apr;138(4):611-9. Epub 2012 Jan 3.

 

Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers. 

Yoon JH, Choi YJ, Kim SG, Nam SW, Lee JY, Park WS. 

Tumour Biol. 2012 Apr;33(2):485-94. Epub 2011 Dec 13.

 

Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. 

Noh JH, Jung KH, Kim JK, Eun JW, Bae HJ, Xie HJ, Chang YG, Kim MG, Park WS, Lee JY, Nam SW.

PLoS One. 2011;6(11):e28103. Epub 2011 Nov 23.

 

Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. 

Yoon JH, Park JK, Kang YH, Park YK, Nam SW, Lee JY, Park WS. 

APMIS. 2011 Nov;119(11):762-8. doi: 10.1111/j.1600-0463.2011.02802.x. Epub 2011 Aug 22.

 

Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers.

Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, Lee YS, Park WS. J Cancer Res Clin Oncol. 2011 Nov;137(11):1697-704. Epub 2011 Sep 7.

 

O⁶-methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomas.

Yang SH, Lee KS, Yang HJ, Jeon BH, Lee YS, Nam SW, Chung DS, Lee SW, Hong YK.

 J Neurooncol. 2012 Jan;106(2):243-50. Epub 2011 Jul 27.

 

Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells. 

Hwang SJ, Suh MJ, Yoon JH, Kim MR, Ryu KS, Nam SW, Donahoe PK, Maclaughlin DT, Kim JH.

Int J Oncol. 2011 Oct;39(4):811-20. doi: 10.3892/ijo.2011.1042. Epub 2011 May 13.

 

Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. 

Yoon JH, Song JH, Zhang C, Jin M, Kang YH, Nam SW, Lee JY, Park WS. 

J Pathol. 2011 Apr;223(5):618-25. doi: 10.1002/path.2838. Epub 2011 Feb 21.

 

Dynamic alterations in integrin α4 expression by hypoxia are involved in trophoblast invasion during early implantation.

Na KH, Lee HJ, Choi JH, Eun JW, Nam SW, Yoon TK, Kim GJ.

J Cell Biochem. 2012 Feb;113(2):685-94. doi: 10.1002/jcb.23398.

 

Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas.

Kim H, Eun JW, Lee H, Nam SW, Rhee H, Koh KH, Kim H.

Exp Mol Pathol. 2011 Apr;90(2):201-9. doi: 10.1016/j.yexmp.2010.12.004. Epub 2010 Dec 24

 

Molecular signature for early detection and prediction of polycyclic aromatic hydrocarbons in peripheral blood.

Jung KH, Noh JH, Eun JW, Kim JK, Bae HJ, Xie H, Jang JJ, Ryu JC, Park WS, Lee JY, Nam SW. Environ Sci Technol. 2011 Jan 1;45(1):300-6. Epub 2010 Dec 6.

 

Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Jang JJ, Ryu JC, Park WS, Lee JY, Nam SW.

Toxicol Appl Pharmacol. 2011 Jan 15;250(2):162-9. Epub 2010 Oct 16.

 

Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.

Kim JK, Kim PJ, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Shan JM, Ping WY, Park WS, Lee JY, Nam SW.

Oncol Rep. 2010 Sep;24(3):607-12.

 

Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers.

Cao Z, Song JH, Kang YW, Yoon JH, Nam SW, Lee JY, Park WS.

Pathol Int. 2010 Aug;60(8):559-65.

 

Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers.

Song JH, Cao Z, Yoon JH, Nam SW, Kim SY, Lee JY, Park WS.

Pathol Oncol Res. 2011 Mar;17(1):67-74. Epub 2010 Jun 4.

 

Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Park WS, Lee JY, Nam SW.

J Cell Biochem. 2010 Jun 1;110(3):687-96.

 

Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis.

Eun JW, Kwack SJ, Noh JH, Jung KH, Kim JK, Bae HJ, Xie H, Ryu JC, Ahn YM, Park WS, Lee JY, Rhee GS, Nam SW.

Toxicol Lett. 2010 May 19;195(1):60-7. Epub 2010 Feb 24.

 

 

2007~2009

 

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.

Int J Oncol. 2009 Dec;35(6):1257-64.

 

Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.

Bae HJ, Eun JW, Noh JH, Kim JK, Jung KH, Xie HJ, Park WS, Lee JY, Nam SW.

Oncol Rep. 2009 Sep;22(3):475-80.

 

Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells.

Noh JH, Song JH, Eun JW, Kim JK, Jung KH, Bae HJ, Xie HJ, Ryu JC, Ahn YM, Wee SJ, Park WS, Lee JY, Nam SW.

Int J Mol Med. 2009 Aug;24(2):205-26.

 

The Glu346Lys polymorphism and frameshift mutations of the Methyl-CpG Binding Domain 4 gene in gastrointestinal cancer.

Song JH, Maeng EJ, Cao Z, Kim SY, Nam SW, Lee JY, Park WS.

Neoplasma. 2009;56(4):343-7.

 

Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma.

Bae HJ, Song JH, Noh JH, Kim JK, Jung KH, Eun JW, Xie HJ, Ryu JC, Ahn YM, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS, Nam SW.

Neoplasma. 2009;56(4):331-4.

 

Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.

Nam SW, Jo YS, Eun JW, Song JY, Ryu KS, Lee JY, Lee JM, Maclaughlin DT, Kim JH.

Int J Mol Med. 2009 May;23(5):589-96.

 

Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.

Eun JW, Kwack SJ, Noh JH, Jung KH, Kim JK, Bae HJ, Xie H, Ryu JC, Ahn YM, Min JH, Park WS, Lee JY, Rhee GS, Nam SW.

Toxicol Appl Pharmacol. 2009 May 15;237(1):91-101. Epub 2009 Mar 10.

 

Mutational analysis of JAK1 gene in human hepatocellular carcinoma.

Xie HJ, Bae HJ, Noh JH, Eun JW, Kim JK, Jung KH, Ryu JC, Ahn YM, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS, Nam SW.

Neoplasma. 2009;56(2):136-40.

 

Overexpression of Wnt-2 in colorectal cancers.

Park JK, Song JH, He TC, Nam SW, Lee JY, Park WS.

Neoplasma. 2009;56(2):119-23.

 

The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients.

Cao Z, Song JH, Park YK, Maeng EJ, Nam SW, Lee JY, Park WS.

Neoplasma. 2009;56(2):114-8.

 

Genetic and epigenetic analysis of the VHL gene in gastric cancers.

Cao Z, Song JH, Kim CJ, Cho YG, Kim SY, Nam SW, Lee JY, Park WS.

Acta Oncol. 2008;47(8):1551-6.

 

Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis.

Eun JW, Ryu SY, Noh JH, Lee MJ, Jang JJ, Ryu JC, Jung KH, Kim JK, Bae HJ, Xie H, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW.

Toxicology. 2008 Jul 30;249(2-3):176-83. Epub 2008 May 14.

 

Activation-induced cytidine deaminase expression in gastric cancer.

Kim CJ, Song JH, Cho YG, Cao Z, Kim SY, Nam SW, Lee JY, Park WS.

Tumour Biol. 2007;28(6):333-9. Epub 2008 Apr 4.

 

No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients.

Cho YG, Choi BJ, Song JH, Kim CJ, Cao Z, Nam SW, Lee JY, Park WS.

Neoplasma. 2008;55(3):256-60.

 

Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.

Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS.

Histopathology. 2008 Apr;52(5):552-9. Epub 2008 Feb 23.

 

Genetic alterations of the Cdx2 gene in gastric cancer.

Song JH, Kim CJ, Cho YG, Chae JS, Cao Z, Nam SW, Lee JY, Park WS.

APMIS. 2008 Jan;116(1):74-80.

KLF6 IVS1 -27G/A polymorphism with susceptibility to gastric cancers in Korean.

Cho YG, Lee HS, Song JH, Kim CJ, Park YK, Nam SW, Yoo NJ, Lee JY, Park WS.

Neoplasma. 2008;55(1):47-50.

 

Aspartic acid repeat polymorphism of the asporin gene with susceptibility to osteoarthritis of the knee in a Korean population.

Song JH, Lee HS, Kim CJ, Cho YG, Park YG, Nam SW, Lee JY, Park WS.

Knee. 2008 Jun;15(3):191-5. Epub 2008 Feb 21.

 

[Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].

Lee SW, Kang SB, Kim YS, Nam SW, Lee DS, Lee HK, Han SW.

Korean J Gastroenterol. 2007 Mar;49(3):152-7. Korean.

 

Genetic analysis of the DBC2 gene in gastric cancer.

Cho YG, Choi BJ, Kim CJ, Song JH, Zhang C, Nam SW, Lee JY, Park WS.

Acta Oncol. 2008;47(3):366-71. Epub 2007 Sep 28.

 

Genetic alterations of the ATBF1 gene in gastric cancer.

Cho YG, Song JH, Kim CJ, Lee YS, Kim SY, Nam SW, Lee JY, Park WS.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4355-9.

 

Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.

Nam SW, Jung JJ, Bae SH, Choi JY, Yoon SK, Cho SH, Han JY, Han NI, Yang JM, Lee YS.

Korean J Intern Med. 2007 Jun;22(2):73-6.

 

Genetic and epigenetic analysis of the KLF4 gene in gastric cancer.

Cho YG, Song JH, Kim CJ, Nam SW, Yoo NJ, Lee JY, Park WS.

APMIS. 2007 Jul;115(7):802-8.

 

Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas.

Lee SH, Jeong EG, Nam SW, Lee JY, Yoo NJ, Lee SH.

Pathology. 2007 Jun;39(3):326-9.

 

Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.

Song JH, Kim CJ, Cho YG, Park YK, Nam SW, Yoo NJ, Lee JY, Park WS.

Neoplasma. 2007;54(3):235-9.

 

Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability.

Kim CJ, Lee JH, Song JW, Cho YG, Kim SY, Nam SW, Yoo NJ, Park WS, Lee JY.

Eur J Surg Oncol. 2007 Jun;33(5):580-5. Epub 2007 Apr 3.

 

Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas.

Kim MR, Jeong EG, Chae B, Lee JW, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH.

Dig Dis Sci. 2007 Oct;52(10):2751-6. Epub 2007 Mar 28.

 

Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers.

Kim CJ, Choi BJ, Song JH, Park YK, Cho YG, Nam SW, Yoo NJ, Lee JY, Park WS.

Pathol Int. 2007 Apr;57(4):178-82.

 

Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers.

Song JH, Kim CJ, Cho YG, Kwak HJ, Nam SW, Yoo NJ, Lee JY, Park WS.

APMIS. 2007 Feb;115(2):164-8.

 

Somatic mutations of the beta-TrCP gene in gastric cancer.

Kim CJ, Song JH, Cho YG, Kim YS, Kim SY, Nam SW, Yoo NJ, Lee JY, Park WS.

APMIS. 2007 Feb;115(2):127-33.

 

 

2001~2006

 

Mutational analysis of PTPRT phosphatase domains in common human cancers.

Lee JW, Jeong EG, Lee SH, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2007 Jan;115(1):47-51.

 

Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.

Yoo NJ, Lee SH, Jeong EG, Lee JW, Soung YH, Nam SW, Kim SH, Lee JY, Lee SH.

Pathol Res Pract. 2007;203(2):73-8. Epub 2007 Jan 4.

 

Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas.

Jeong EG, Lee JW, Soung YH, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2006 Dec;114(12):867-73.

 

Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas.

Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ, Lee SH.

Oncology. 2006;70(4):285-9. Epub 2006 Oct 16.

 

Absence of BH3 domain mutations in the proapoptotic Bcl-2 gene family in non-Hodgkin lymphomas.

Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH.

Acta Haematol. 2006;116(3):213-5. No abstract available.

 

Mitochondrial microsatellite instability of colorectal cancer stroma.

Kim HS, Lim HS, Lee SH, Lee JW, Nam SW, Park WS, Lee YS, Lee JY, Yoo NJ.

Int J Cancer. 2006 Dec 1;119(11):2607-11.

 

Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.

Lee JW, Kim MR, Soung YH, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2006 Sep;114(9):646-50.

 

Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas.

Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH.

Pathology. 2006 Aug;38(4):312-5.

 

Pin1 gene mutation is a rare event in gastric cancer.

Kim CJ, Song JH, Cho YG, Chae HS, Nam SW, Yoo NJ, Lee JY, Park WS.

APMIS. 2006 Jul-Aug;114(7-8):518-22.

 

Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.

Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

J Gastroenterol Hepatol. 2006 Aug;21(8):1286-9.

 

Genetic alterations of the KLF6 gene in colorectal cancers.

Cho YG, Choi BJ, Kim CJ, Song JW, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

APMIS. 2006 Jun;114(6):458-64.

 

Mutational analysis of MYC in common epithelial cancers and acute leukemias.

Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH.

APMIS. 2006 Jun;114(6):436-9.

 

Mutational analysis of the hCDC4 gene in gastric carcinomas.

Lee JW, Soung YH, Kim HJ, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

Eur J Cancer. 2006 Sep;42(14):2369-73. Epub 2006 Jul 5.

 

Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas.

Cho YG, Kim CJ, Song JH, Rhie DJ, Park YK, Kim SY, Nam SW, Yoo NJ, Lee JY, Park WS.

Exp Mol Med. 2006 Jun 30;38(3):247-55.

 

Altered expression of the KLF4 in colorectal cancers.

Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY, Nam SW, Yoo NJ, Lee JY, Park WS.

Pathol Res Pract. 2006;202(8):585-9. Epub 2006 Jun 30.

 

Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas.

Yoo NJ, Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Lee SH.

Dig Liver Dis. 2006 Sep;38(9):683-7. Epub 2006 Jun 27.

 

Immunohistochemical analysis of apoptosis-inducing factor (AIF) expression in gastric carcinomas.

Lee JW, Jeong EG, Soung YH, Kim SY, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

Pathol Res Pract. 2006;202(7):497-501. Epub 2006 May 24.

 

Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas.

Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

APMIS. 2006 Apr;114(4):292-7.

 

A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.

Jang JW, Bae SH, Choi JY, Oh HJ, Kim MS, Lee SY, Kim CW, Chang UI, Nam SW, Cha SB, Lee YJ, Chun HJ, Choi BG, Byun JY, Yoon SK.

Cancer Chemother Pharmacol. 2007 Jan;59(1):9-15. Epub 2006 Apr 14.

 

Aberrant expression of krUppel-like factor 6 protein in colorectal cancers.

Cho YG, Choi BJ, Song JW, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

World J Gastroenterol. 2006 Apr 14;12(14):2250-3.

 

Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells.

Noh JH, Ryu SY, Eun JW, Song J, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Lee SN, Nam SW.

Mol Cell Biochem. 2006 Aug;288(1-2):91-106. Epub 2006 Apr 7.

 

Altered expression of CDX2 in colorectal cancers.

Choi BJ, Kim CJ, Cho YG, Song JH, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

APMIS. 2006 Jan;114(1):50-4.

 

BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder.

Soung YH, Lee JW, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

Pathology. 2006 Feb;38(1):33-4.

 

Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.

Nam SW, Lee JH, Noh JH, Lee SN, Kim SY, Lee SH, Park CK, Ahn YM, Park WS, Yoo NJ, Lee JY.

Eur J Gastroenterol Hepatol. 2006 Mar;18(3):239-47.

 

Mutational analysis of the kinase domain of MYLK2 gene in common human cancers.

Soung YH, Lee JW, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH.

Pathol Res Pract. 2006;202(3):137-40. Epub 2006 Jan 31.

 

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.

Lee JW, Soung YH, Seo SH, Kim SY, Park CH, Wang YP, Park K, Nam SW, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH.

Clin Cancer Res. 2006 Jan 1;12(1):57-61.

 

A case of the hepatocellular carcinoma during the pregnancy and metastasis to the left atrium.

Nam SW, Baek JT, Kang SB, Lee DS, Kim JI, Cho SH, Park SH, Han JY, Ahn BM, Kim JK, Chung KW.

Korean J Hepatol. 2005 Dec;11(4):381-5.

 

JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas.

Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH.

Leuk Lymphoma. 2006 Feb;47(2):313-4.

 

ERBB2 kinase domain mutation in a gastric cancer metastasis.

Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2005 Oct;113(10):683-7.

 

The JAK2 V617F mutation in de novo acute myelogenous leukemias.

Lee JW, Kim YG, Soung YH, Han KJ, Kim SY, Rhim HS, Min WS, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH.

Oncogene. 2006 Mar 2;25(9):1434-6.

 

Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.

Song J, Clair T, Noh JH, Eun JW, Ryu SY, Lee SN, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):967-75. Epub 2005 Oct 3.

 

Somatic mutations of the ERBB4 kinase domain in human cancers.

Soung YH, Lee JW, Kim SY, Wang YP, Jo KH, Moon SW, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

Int J Cancer. 2006 Mar 15;118(6):1426-9.

 

Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.

Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY.

Hepatology. 2005 Oct;42(4):809-18.

 

Hypermethylation of the RUNX3 gene in hepatocellular carcinoma.

Park WS, Cho YG, Kim CJ, Song JH, Lee YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY.

Exp Mol Med. 2005 Aug 31;37(4):276-81.

 

Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression.

Kim CJ, Cho YG, Park YG, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS.

World J Gastroenterol. 2005 Aug 28;11(32):5006-9.

 

Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Cho YG, Kim CJ, Nam SW, Yoon SH, Lee SH, Yoo NJ, Lee JY, Park WS.

World J Gastroenterol. 2005 Aug 21;11(31):4852-6.

 

ERBB2 kinase domain mutation in the lung squamous cell carcinoma.

Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Wang YP, Jo KH, Moon SW, Song SY, Lee JY, Yoo NJ, Lee SH.

Cancer Lett. 2006 Jun 8;237(1):89-94. Epub 2005 Jul 18.

 

[Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].

Lee DS, Kang SB, Baek JT, Nam SW, Lee KM, Ahn BM, Lee EH, Han SW, Chung IS.

Korean J Gastroenterol. 2005 Jun;45(6):394-400. Korean.

 

Increased expression of histone deacetylase 2 is found in human gastric cancer.

Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW.

APMIS. 2005 Apr;113(4):264-8.

 

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

Lee JW, Soung YH, Kim SY, Nam HK, Park WS, Nam SW, Kim MS, Sun DI, Lee YS, Jang JJ, Lee JY, Yoo NJ, Lee SH.

Clin Cancer Res. 2005 Apr 15;11(8):2879-82.

 

Genetic alterations of the KLF6 gene in gastric cancer.

Cho YG, Kim CJ, Park CH, Yang YM, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

Oncogene. 2005 Jun 30;24(28):4588-90.

 

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

Soung YH, Lee JW, Kim SY, Seo SH, Park WS, Nam SW, Song SY, Han JH, Park CK, Lee JY, Yoo NJ, Lee SH.

Virchows Arch. 2005 May;446(5):483-8. Epub 2005 Apr 7.

 

Spontaneous regression of a large hepatocellular carcinoma with skull metastasis.

Nam SW, Han JY, Kim JI, Park SH, Cho SH, Han NI, Yang JM, Kim JK, Choi SW, Lee YS, Chung KW, Sun HS.

J Gastroenterol Hepatol. 2005 Mar;20(3):488-92.

 

CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas.

Soung YH, Lee JW, Kim SY, Jang J, Park YG, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

Cancer Res. 2005 Feb 1;65(3):815-21.

 

Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.

Park JY, Park WS, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park CK.

Liver Int. 2005 Feb;25(1):70-6.

 

Mutational analysis of the ARAF gene in human cancers.

Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Min WS, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2005 Jan;113(1):54-7.

 

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

Oncogene. 2005 Feb 17;24(8):1477-80.

 

Mutation of FADD gene is rare in human colon and stomach cancers.

Soung YH, Lee JW, Kim SY, Nam SW, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2004 Sep;112(9):595-7.

 

Altered expression of KCNK9 in colorectal cancers.

Kim CJ, Cho YG, Jeong SW, Kim YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

APMIS. 2004 Sep;112(9):588-94.

 

Application of amplified RNA and evaluation of cRNA targets for spotted-oligonucleotide microarray.

Park JY, Kim SY, Lee JH, Song J, Noh JH, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1346-52.

 

Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas.

Soung YH, Lee JW, Kim SY, Sung YJ, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

Oncogene. 2005 Jan 6;24(1):141-7.

 

Loss of caspase-2, -6 and -7 expression in gastric cancers.

Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Lee SH.

APMIS. 2004 Jun;112(6):330-5.

 

Inactivating mutations of the Siah-1 gene in gastric cancer.

Kim CJ, Cho YG, Park CH, Jeong SW, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS.

Oncogene. 2004 Nov 11;23(53):8591-6.

 

Genetic alterations of the MYH gene in gastric cancer.

Kim CJ, Cho YG, Park CH, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

Oncogene. 2004 Sep 2;23(40):6820-2.

 

Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.

Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.

Cancer Chemother Pharmacol. 2004 Nov;54(5):415-20.

 

Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase.

Lee SH, Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Kim SH, Yoo NJ, Lee JY.

APMIS. 2004 Apr-May;112(4-5):233-8.

 

Somatic mutations of CASP3 gene in human cancers.

Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

Hum Genet. 2004 Jul;115(2):112-5. Epub 2004 May 4.

 

Inactivating mutation of the pro-apoptotic gene BID in gastric cancer.

Lee JH, Soung YH, Lee JW, Park WS, Kim SY, Cho YG, Kim CJ, Seo SH, Kim HS, Nam SW, Yoo NJ, Lee SH, Lee JY.

J Pathol. 2004 Apr;202(4):439-45.

 

Inactivating mutations of proapoptotic Bad gene in human colon cancers.

Lee JW, Soung YH, Kim SY, Nam SW, Kim CJ, Cho YG, Lee JH, Kim HS, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH.

Carcinogenesis. 2004 Aug;25(8):1371-6. Epub 2004 Mar 19.

 

Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas.

Kim CJ, Cho YG, Park JY, Kim TY, Lee JH, Kim HS, Lee JW, Song YH, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.

Eur J Cancer. 2004 Jan;40(1):136-41.

 

BRAF mutations in non-Hodgkin's lymphoma.

Lee JW, Yoo NJ, Soung YH, Kim HS, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Ko YH, Kim SH, Nam SW, Lee JY, Lee SH.

Br J Cancer. 2003 Nov 17;89(10):1958-60.

 

BRAF and KRAS mutations in stomach cancer.

Lee SH, Lee JW, Soung YH, Kim HS, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Nam SW, Kim SH, Lee JY, Yoo NJ.

Oncogene. 2003 Oct 9;22(44):6942-5.

 

Mutational analysis of salvador gene in human carcinomas.

Yoo NJ, Soung YH, Lee JW, Park WS, Kim SY, Nam SW, Han JH, Kim SH, Lee JY, Lee SH.

APMIS. 2003 Jun;111(6):595-8.

 

Inactivating mutations of caspase-8 gene in colorectal carcinomas.

Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Jeong SW, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

Gastroenterology. 2003 Sep;125(3):708-15.

 

A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer.

Park WS, Cho YG, Park JY, Kim CJ, Lee JH, Kim HS, Lee JW, Song YH, Park CH, Park YK, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY.

J Korean Med Sci. 2003 Aug;18(4):501-4.

 

Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer.

Cho YG, Nam SW, Kim TY, Kim YS, Kim CJ, Park JY, Lee JH, Kim HS, Lee JW, Park CH, Song YH, Lee SH, Yoo NJ, Lee JY, Park WS.

APMIS. 2003 May;111(5):539-45.

 

Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.

Chung KW, Han NI, Choi SW, Ahn BM, Yoon SK, Nam SW, Lee YS, Han JY, Sun HS.

J Korean Med Sci. 2002 Dec;17(6):795-800.

 

Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.

Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Kang CS, Kim KM, Jang JJ, Nam SW, Lee JY, Yoo NJ.

Oncogene. 2001 Jan 18;20(3):399-403.

 

 

International journal publications (SCIE)

 

 

 

1. Lack of association of SCN2A and KCNJ10 polymorphisms in Korean Children with epilepsy: intractability and replase of epilepsy.

윤정환,최병준,박용규,강영휘,남석우,이정용,박원상.

MOLECULAR & CELLULAR TOXICOLOGY. 201203, 8(1), 61~67. IF=0.88

 

2. TNF-α and TNF-β Polymorphisms are Associated with Susceptibility to Osteoarthritis in a Korean Population.

한린,송주현,윤정환,박용규,이석우,최유진,남석우,이정용,박원상.

THE KOREAN JOURNAL OF PATHOLOGY(구.대한병리학회지,대한세포병리학회지) 2007년 2월 이후 게재. 201202, 46(1), 30~37. IF=0.134

 

3. Overexpression of SIRT2 contributes tumor cell growth in hepatocellular carcinomas.

사홍건,정광화,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 201112, 7(4), 367~374. IF=0.88

 

4. Hepatic proteome responses against benz[a]anthracene in the rat.

Seul-Ki Park,Yoo-Na Seo,남석우,Mi-Young Lee.

BIOCHIP JOURNAL. 201112, 5(4), 309~316. IF=0.86

 

5. O(6)-methylguanine DNA methyltransferase gene promoter methylation status in glioblastoma and its correlation with other prognostic markers.

이성학,남석우,홍용길,강창석,이연수.

MOLECULAR & CELLULAR TOXICOLOGY. 201112, 7(4), 425~430. IF=0.88

 

6. Assessment of human biomonitoring and DNA microarray analysis in the vicinity population on an industrial complex.

이경호,정은경,문정숙,남석우,이미영,손부순.

MOLECULAR & CELLULAR TOXICOLOGY. 201109, 7(3), 207~219. IF=0.88

 

7. Copy Number Alterations of BCAS1 in Squamous Cell Carcinomas.

김유임,이아원,제니퍼김,이범희,이성학,남석우,이석형,박원상,유남진,이정용,김상호,김수영.

THE KOREAN JOURNAL OF PATHOLOGY(구.대한병리학회지,대한세포병리학회지) 2007년 2월 이후 게재. 201106, 45(3), 271~275. IF=0.134

 

8. Evaluation and application of RNAs derived from laser microdissected specimens using DNA microarray for expression genomics. 은정우,정호상,김은정,안영민,박원상,이정용,남석우.

BIOCHIP JOURNAL. 201012, 4(4), 322~328. IF=0.86

 

9. Ethylbenzen-induced differential protein profiles in rat liver.

박슬기,남석우,이미영.

BIOCHIP JOURNAL. 201012, 4(4), 272~278. IF=0.86

 

10. Proteomic analysis of rat liver proteins differentially induced by trichloroethylene.

박슬기,남석우,류채천,함주현,이미영.

BIOCHIP JOURNAL. 201003, 4(), 57~62. IF=0.86

 

11. Immunohistochemical Analysis of TBX3 and beta-catenin in Gastric Cancers.

송재휘,윤정환,강영휘,조장,남석우,이정용,박원상.

MOLECULAR & CELLULAR TOXICOLOGY. 200912, 5(4), 328~334. IF=0.88

 

12. Decreased Expression of the Suppressor of Cytokine Signaling 6 in Human Hepatocellular Carcinoma.

배현진,노지헌,은정우,김정규,정광화,사홍건,안영민,류재천,박원상,이정용,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 200909, 5(), 193~197. IF=0.88

 

13. Somatic mutations of the ENPP2(Autotaxin/lysoPLD) gene in breast cancer.

송재휘,김정규,노지헌,정광화,은정우,김창재,배현진,사홍건,안영민,이석형,유남진,이정용,박원상,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 200712, 3(4), 262~266. IF=0.88

 

14. Genetic alterations of the CHOP gene in gastric cancers.

송재휘,박종경,윤정환,남석우,이정용,박원상.

MOLECULAR & CELLULAR TOXICOLOGY. 2011.03, 7(1), 1~6. IF=0.88

 

15. Decreased expression of TFF2 and gastric carcinogenesis.

정광화,김범준,김정규,노지헌,은정우,배현진,사홍건,김미선,왕잉핑,박원상,이정용,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 2010.09, 6(3), 261~269. IF=0.88

 

16. TGFBR2 frameshift mutation in gastric tumors with microsatellite instability.

송재휘,이화성,윤정환,강영휘,남석우,이정용,박원상.

MOLECULAR & CELLULAR TOXICOLOGY. 2010.09, 6(3), 321~326. IF=0.88

 

17. Loss-of-function mutations in the transcription factor 7 (T cell factor-1) gene in hepatogastrointestinal cancers.

정광화,윤강준,송재휘,이성학,은정우,노지헌,김정규,배현진,이장은,김상우,최명규,김수영,박원상,남석우,이정용.

MOLECULAR & CELLULAR TOXICOLOGY. 2010.09, 6(3), 271~278. IF=0.88

 

18. Growth Differentiation Factor 5 (GDF5) Core Promoter Polymorphism Is Not Associated with Susceptibility to Osteoarthritis of the Knee in the Korean Population.

조장,이화성,송재휘,윤정환,박용규,남석우,이정용,박원상.

THE KOREAN JOURNAL OF PATHOLOGY(구.대한병리학회지,대한세포병리학회지) 2007년 2월 이후 게재.

2010.08, 44(4), 404~409. IF=0.134

 

19. TNF-alpha and TNF-beta polymorphisms with susceptibility to gastric cancer in a Korean population.

윤정환,송재휘,강영휘,박용규,조장,남석우,이정용,박원상.

MOLECULAR & CELLULAR TOXICOLOGY. 2010.06, 6(2), 161~167. IF=0.88

 

20. Molecular classification and characterization of human gastric adenocarcinoma through DNA Microarray.

사홍건,은정우,노지헌,정광화,김정규,김수영,이석형,박원상,유남진,이정용,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 2007.09, 3(3), 190~194. IF=0.88

 

21. Increased expression of histone deacetylase 2 is found in human hepatocellular carcinoma.

노지헌,은정우,류소연,정광화,김정규,이석형,박원상,유남진,이정용,남석우.

MOLECULAR & CELLULAR TOXICOLOGY. 2006.09, 2(3), 166~169. IF=0.88

 

 

Domestic journal publications

 

 

위암에서 새로운 종양원인 유전자 Nemo-like Kinase 의 발현 증가.

김민규,정광화,남석우

대한약학회지 2012, 56(6), 358~363.

 

간암에서 FGFR3 mRNAdml rhkqkfgusrhk FGFR3 유전자의 돌연변이 분석.

장영균,배현진,남석우

대한약학회지 2012, 56(6), 352~357.

 

아밀로이드베타단백으로 자극된 사람 별아교세포종에 Ibuprofen 투여 후 세포 내 유전자 발현 탐색.

최영숙,은정우,남석우,김상호. 노인병(JOURNAL OF THE KOREAN GERIATRICS SOCIETY).

2011.09, 15(3), 144~161. 학진등재후보지


Genetic and expression analysis of the sirt1 gene in gastric cancers.

조장,송재휘,강영휘,윤정환,남석우,이정용,박원상.

대한위암학회지. 201009, 10(3), 91~98. 학진등재후보지

 

PDGF-BB를 처리한 hTERT 간성상세포주의 유전자 발현 양상과 Wnt 신호 활성 양상 분석.

신혜원,박수영,이경분,신은,남석우,이정용,장자준.

THE KOREAN JOURNAL OF HEPATOLOGY(대한간학회지). 2009.12, 15(4), 486~495. 학진등재지

 

Oligonucleotide microarray와 cDNA microarray를 이용한 위암조직의 대단위 유전자 발현 비교.

정광화,김정규,노지헌,은정우,배현진,이석형,박원상,유남진,이정용,남석우.

대한약학회지. 20070901, 51(3), 179~185. 학진등재지

 

실험실내 추간판 연골세포의 운동성 측정실험에서 척색세포에 의해 유도되는 연골종판 연골세포의 화학주성.

김기원,이준석,하기용,유기원,남석우,우영균.

대한척추외과학회지. 20070301, 14(1), 1~7. 학진등재후보지

 

Mutational analysis of pro-apoptotic BAD gene in non-small cell lung cancer.

이종우,송영화,남석우,이정용,유남진,이석형.

JOURNAL OF LUNG CANCER. 20060601, 5(1), 35~38. 국내기타학술지

 

위암에서 EhB2 단백의 발현 양상.

송재휘,김창재,조용구,박조현,남석우,유남진,이정용,박원상.

대한위암학회지. 20060301, 6(1), 25~30. 학진등재후보지

 

혐미부수체 불안정성을 동반한 위암에서 Chk1 유전자의 돌연변이.

이종흔,조용구,송재휘,박조현,김수영,남석우,이석형,유남진,이정용,박원상.

대한위암학회지. 20051201, 5(4), 260~265. 학진등재후보지

 

한국인 위암에서 KLF4 단백 발현 양상.

송재휘,조용구,김창재,박조현,김수영,남석우,이석형,유남진,이정용,박원상.

대한위암학회지. 20050901, 5(3), 199~205. 학진등재후보지

 

Mutational analysis of caspase-7 and 8 genes in non-small cell lung cancers.

송영화,이종우,문석환,조건현,왕영필,김수영,남석우,박원상,이정용,유남진,이석형.

JOURNAL OF LUNG CANCER. 20050601, 4(1), 38~41. 국내기타학술지

 

대장암에서 세포자멸사 유발성 bcl-2 Family 유전자의 돌연변이 연구.

송영화,이종우,김수영,남석우,박원상,이정용,유남진,이석형.

THE KOREAN JOURNAL OF PATHOLOGY(2007년 2월 이전 게재). 20050401, 2005(39), 168~171. 학진등재후보지

 

한국인 위암에서 KLF6 단백 발현 양상.

조용구,김창재,박조현,김수영,남석우,이석형,유남진,이정용,박원상.

대한위암학회지. 20050301, 5(1), 34~39. 학진등재후보지

 

위장관 간질성 종양의 epidermal growth factor receptor 유전자 돌연변이 연구.

유남진,이종우,송영화,전해명,남석우,김수영,박원상,이정용,이석형.

대한위암학회지. 20041201, 4(4), 268~271. 학진등재후보지

 

DNA Microarray Analysis of the Gene Expression Profile of Activated Human Umbilical Vein Endothelial Cells.

김선용,오호균,이수영,남석우,이정용,안현영,신종철,홍용길,조영애.

생명과학회지. 20041001, 14(5), 874~881. 학진등재지

 

Expression, Secretion and Purification of Histitdine-Tagged Autotaxin(NPP2) from Insect Cells Media.

이종한,송재휘,이종흔,안영민,김수영,이석형,박원상,유남진,홍성렬,이정용,남석우.

대한약학회지. 20031201, 47(6), 410~416. 학진등재후보지

 

위암에서 발견된 돌연변이형 Fas 단백의 기능적 결함.

박원상,조용구,김창재,박조현,김영실,김수영,남석우,이석형,유남진,이정용.

대한위암학회지. 20031201, 3(4), 186~190. 학진등재후보지

 

위암에서 여러 종양억제유전자 부위의 이형접합성 소실과 현미 부수체 부안정성.

조용구,김창재,박조현,김영실,김수영,남석우,이석형,유남진,이정용,박원상.

대한위암학회지. 20031201, 3(4), 214~220. 학진등재후보지

 

A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer.

박원상,조용구,박직영,김창재,이종흔,김홍석,이종우,송영화,박조현,박용규,김수영,남석우,이석형,유남진,이정용.

KOREAN ACAD MEDICAL SCIENCES. 2003.08, 18, 501~504. 국내기타학술지

 

한국인 위암에서 Caspase 2 단백 발현 양상.

김창재,박직영,이종흔,조용구,이종우,송영화,김영실,박조현,남석우,이석형,유남진,이정용,박원상.

대한위암학회지. 20030301, 3(1), 38~43. 학진등재후보지